1380329-78-1

Basic information

• Product Name: 4-(azetidine-1-carbonyl)-2-methyl-2H-pyrazole-3-carboxylic acid (2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)amide
• Synonyms: 4-(azetidine-1-carbonyl)-2-methyl-2H-pyrazole-3-carboxylic acid (2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)amide
• CAS NO: 1380329-78-1
• Molecular Weight: 401.428
• Mol File: 1380329-78-1.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 4-(azetidine-1-carbonyl)-2-methyl-2H-pyrazole-3-carboxylic acid (2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)amide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(azetidine-1-carbonyl)-2-methyl-2H-pyrazole-3-carboxylic acid (2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)amide(1380329-78-1)
• EPA Substance Registry System: 4-(azetidine-1-carbonyl)-2-methyl-2H-pyrazole-3-carboxylic acid (2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)amide(1380329-78-1)

Safety Data

• Hazardous Substances Data: 1380329-78-1(Hazardous Substances Data)

Upstream product

• 503-29-7 azetidine 
• 1380329-77-0 1-methyl-5-(2-phenyl[1,2,4]triazolo[1,5-a]pyridin-7-ylcarbamoyl)-1H-pyrazole-4-carboxylic acid 
• 84249-14-9 2-amino-4-bromopyridine 
• 1202704-61-7 1,2-diamino-4-bromopyridin-1-ium-2,4,6-trimethylbenzenesulfonate 
• 1380331-12-3 7-bromo-2-phenyl-[1,2,4]triazolo[1,5-a]pyridine 
• 1380331-13-4 (2-phenyl[1,2,4]triazolo[1,5-a]pyridin-7-yl)carbamic acid tert-butyl ester 
• 1380331-14-5 2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-ylamine 
• 81303-65-3 4-(ethoxycarbonyl)-1-methyl-1H-pyrazole-5-carboxylic acid 
• 81303-52-8 ethyl 5-carbamoyl-1-methyl-1H-pyrazole-4-carboxylate 
• 1380329-76-9 1-methyl-5-(2-phenyl[1,2,4]triazolo[1,5-a]pyridin-7-ylcarbamoyl)-1H-pyrazole-4-carboxylic acid methyl ester 

Relevant articles and documents

Palladium-Catalyzed C-N Coupling of Pyrazole Amides with Triazolo- And Imidazopyridine Bromides in Ethanol

An efficient palladium-catalyzed coupling between a pyrazole amide and a heteroaryl bromide was developed to enable the streamlined synthesis of a lead candidate for schizophrenia treatment. Process robustness and scalability were achieved using ethanol a

TRIAZOLOPYRIDINE COMPOUNDS

The invention is concerned with triazolopyridine compounds of formula (I) wherein R1, R2, R3 and R4 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These